Upgrade to SI Premium - Free Trial

Avidity Biosciences Inc. (RNA)

11.94 -0.36 (2.93%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (9/2/26)
- M&A (3/31/15 *Est)

Latest Headlines

Leerink Partners Starts Atrium Therapeutics (RNA) at Outperform May 15, 2026 6:08 AM - StreetInsider Atrium Therapeutics Reports First Quarter 2026 Financial Results May 14, 2026 4:40 PM - PR NewsWire Atrium Therapeutics receives $15 million milestone from Bristol Myers Squibb April 23, 2026 8:01 AM - StreetInsider Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration April 23, 2026 8:00 AM - PR NewsWire Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 20, 2026 10:46 PM - PR NewsWire Wells Fargo Starts Avidity Biosciences (RNA) at Overweight March 10, 2026 4:24 PM - StreetInsider Full Article List